Physician prescribing of anorexigenics for weight loss in Salt Lake County, Utah

被引:3
作者
Gay, C
Shane-McWhorter, L
Williams, K
Stone, MB
机构
[1] Univ Utah, Coll Pharm, Dept Pharm Practice, Salt Lake City, UT 84112 USA
[2] Univ Utah, Hlth Sci Ctr, Sch Med, Dept Family & Prevent Med, Salt Lake City, UT USA
[3] Family Practice Residency Idaho, Boise, ID USA
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 08期
关键词
D O I
10.1592/phco.20.11.967.35267
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this survey of primary care physicians in Salt Lake County, Utah, was to determine how many of these providers were prescribing anorexigenics (antiobesity drugs) and to evaluate their knowledge of side effects and drug interactions. A confidential survey was sent to 377 family practice, internal medicine, and obstetrics-gynecology physicians, of whom 236 (62.5%) responded. Of those who answered the survey completely, 146 (65.2%) prescribed anorexigenics to 5107 patients. Family practice physicians, male physicians less than 40 years old, and internal medicine physicians less than 40 years old prescribed anorexigenics more frequently than their counterparts. Female physicians (vs male) and female family practice physicians (vs male family practice physicians) reported a higher proportion of psychiatric comorbidity among patients for whom they prescribed the drugs. Respondents had limited knowledge of side effects and drug interactions of anorexigenics. Better understanding of physicians' prescribing patterns of these agents is relevant for current and future optimal treatment of obesity.
引用
收藏
页码:967 / 973
页数:7
相关论文
共 19 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]   Annual deaths attributable to obesity in the United States [J].
Allison, DB ;
Fontaine, KR ;
Manson, JE ;
Stevens, J ;
VanItallie, TB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1530-1538
[3]  
*AM COLL CARD, 1997, REC PAT WHO HAV US A
[4]   USE AND ABUSE OF APPETITE-SUPPRESSANT DRUGS IN THE TREATMENT OF OBESITY [J].
BRAY, GA .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (07) :707-713
[5]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1061
[6]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[7]  
CUMMINGS SM, 1997, J AM DIET ASSOC, V97, P71
[8]   A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation [J].
Jick, H ;
Vasilakis, C ;
Weinrauch, LA ;
Meier, CR ;
Jick, SS ;
Derby, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :719-724
[9]   The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs [J].
Khan, MA ;
Herzog, CA ;
St Peter, JV ;
Hartley, GG ;
Madlon-Kay, R ;
Dick, CD ;
Asinger, RW ;
Vessey, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :713-718
[10]  
MCCANN U, 1994, J PHARMACOL EXP THER, V269, P792